Quantbot Technologies LP Sells 2,738 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Quantbot Technologies LP lowered its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,347 shares of the medical device company’s stock after selling 2,738 shares during the quarter. Quantbot Technologies LP’s holdings in Cooper Companies were worth $5,776,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new position in shares of Cooper Companies during the second quarter valued at $25,000. Ashton Thomas Securities LLC bought a new position in Cooper Companies during the 3rd quarter valued at about $25,000. Crewe Advisors LLC boosted its position in Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares in the last quarter. Tortoise Investment Management LLC boosted its position in Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after buying an additional 169 shares in the last quarter. Finally, Covestor Ltd grew its stake in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after buying an additional 200 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Up 0.2 %

Shares of NASDAQ COO opened at $102.64 on Wednesday. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $20.44 billion, a PE ratio of 57.18, a price-to-earnings-growth ratio of 2.21 and a beta of 0.99. The firm’s 50-day moving average is $105.74 and its 200-day moving average is $98.39. The Cooper Companies, Inc. has a 1 year low of $82.21 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the firm earned $0.84 earnings per share. Equities analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on COO shares. Robert W. Baird lifted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Wells Fargo & Company increased their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Piper Sandler lifted their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Finally, Morgan Stanley upped their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Insider Transactions at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This trade represents a 24.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 in the last three months. Insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.